Entry Point Capital, LLC Vericel Corp Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Vericel Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 3,075 shares of VCEL stock, worth $133,332. This represents 0.21% of its overall portfolio holdings.
Number of Shares
3,075
Previous 1,848
66.4%
Holding current value
$133,332
Previous $96.1 Million
46.76%
% of portfolio
0.21%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding VCEL
# of Institutions
267Shares Held
48.4MCall Options Held
91.1KPut Options Held
39.8K-
Black Rock Inc. New York, NY8.06MShares$349 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.42MShares$192 Million4.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$149 Million0.0% of portfolio
-
State Street Corp Boston, MA2.48MShares$108 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.04MShares$88.5 Million1.42% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.05B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...